TPN bag (patient specific) recall
FDA recall D-0524-2026 · initiated Dec 27, 2025
Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles recalled TPN bag (patient specific) in Dec 2025 — an FDA Class II recall (D-0524-2026) because Incorrect Product Formulation: product did not contain insulin as listed in the label.
May cause temporary or medically reversible harm; low probability of serious harm.
Why it was recalled
Incorrect Product Formulation: product did not contain insulin as listed in the label.
Labelling, packaging or a product mix-up
The wrong information — or the wrong medicine — ended up in the pack. A mix-up is a manufacturing failure that can still be dangerous to swallow.
This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.
Is your product affected? Check the lot number
A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.
Quantity recalled: 1 bag
Details
- Product
- TPN bag (patient specific), Rx# 11-4909703-0-1, Compound Volume 1660 mL per bag, Rx only, Single Dose Injection, Refrigerated Injection, Central Admixture Pharmacy Services, Los Angeles, 13128 Imperial Hwy, Santa Fe Spr., CA 90670
- Recalling company
- Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles
- Classification
- Class II
- Status
- Ongoing
- Type
- Voluntary: Firm initiated
- Distribution
- CA
- Initiated
- Dec 27, 2025
- FDA report date
- May 13, 2026
Frequently asked
- Was TPN bag (patient specific) recalled?
- Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles recalled TPN bag (patient specific) in Dec 2025 — an FDA Class II recall (D-0524-2026) because Incorrect Product Formulation: product did not contain insulin as listed in the label. May cause temporary or medically reversible harm; low probability of serious harm.
- Why was TPN bag (patient specific) recalled?
- Per the FDA enforcement record, the reason for recall D-0524-2026 was: Incorrect Product Formulation: product did not contain insulin as listed in the label.
- Is a recalled TPN bag (patient specific) dangerous to take?
- An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
- Which lots of TPN bag (patient specific) are affected?
- Distributed: CA. The recall covers these lots — Lot #: 11-4909703-0-1, Exp 12/28/2025. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0524-2026.